Growth and development is more than physical development, it is emotional and psychological. Certainly, the FDA Panel can see the folly of such decisions when exposing young teens to such adult concepts and emotional demands.
Children this age are suppose to have parents. Those parents are suppose to be a real part of the picture included in growth and development. A cardinal rule for treating a pediatric patient is recognizing the parent is as much a part of the treatment as the child and physician is. Why then separate that dynamic when it comes to pre-mature sexual behavior?
Why not just hand young teens birth control if there is going to be that much permission to allow over the counter access to emergency contraception?
Children this age are suppose to have parents. Those parents are suppose to be a real part of the picture included in growth and development. A cardinal rule for treating a pediatric patient is recognizing the parent is as much a part of the treatment as the child and physician is. Why then separate that dynamic when it comes to pre-mature sexual behavior?
Why not just hand young teens birth control if there is going to be that much permission to allow over the counter access to emergency contraception?
Dec. 9 (Bloomberg) -- Johnson & Johnson’s birth control patch (click title to entry - thyank you) won the backing of advisers to the U.S. Food and Drug Administration, the second time in two days the group endorsed a contraceptive linked to a higher risk of blood clots.
The benefits of the Ortho Evra patch outweigh the clot dangers, FDA reproductive and drug safety advisory panels said today in a 19-5 vote. The agency should change the information label to better reflect the risk, the panels said at a meeting today in Adelphi, Maryland. The agency doesn’t have to follow the recommendations....
